Updated On: 14 November, 2021 07:07 AM IST | Mumbai | Somita Pal
Around 78,000 children under 15 years are estimated to develop Type 1 annually worldwide; of existing 4,90,000 children living with disorder, 24 per cent are in the European region and 23 per cent in South-East Asia

Young diabetes patients exercise in a gym at a clinic in Mumbai. Pic/AFP
A city hospital’s ongoing research on Type 1 diabetes, also known as juvenile diabetes, has recorded enrolment at 33 per cent since the project began months before the Covid-19 pandemic. The main objective of the project is to research, treat, manage and find a cure for T1D1 diabetes. It is manned by three consulting endocrinologists, two project coordinators, one nurse educator, one counsellor and one dietician.
PD Hinduja Hospital, along with Madras Diabetes Research Foundation, and KEM, Pune, with funding from Hinduja Foundation, started this research and treatment project in November 2019. Till now, the project has enrolled more than 550 patients across three centres. Dr Phulrenu Chauhan, consultant endocrinologist, PD Hinduja Hospital, said, “With Type 1 diabetes, the pancreas does not make insulin. Insulin is a hormone that helps glucose get into your cells to give them energy. Without insulin, too much glucose stays in the blood. Type 1 diabetes is the most common chronic disease in children and adolescents, but does not receive the attention it requires.”